Status:
ACTIVE_NOT_RECRUITING
Prevention of Coronary Heart Disease in Morbidly Obese Patients
Lead Sponsor:
The Hospital of Vestfold
Collaborating Sponsors:
Oslo University Hospital
Conditions:
Morbid Obesity
Hypertension
Eligibility:
All Genders
18-70 years
Brief Summary
The changes in risks of developing coronary heart disease in patients with morbid obesity after different weight loss interventions have not been extensively studied. The primary objective of this stu...
Detailed Description
Patients matching the eligibility criteria were divided into two groups (not randomized). One group underwent a 7 weeks Low-Energy-Diet before bariatric surgery, the other group participated in an int...
Eligibility Criteria
Inclusion
- Morbidly Obese patients with BMI \> 40, or BMI \> 35 with comorbidity such as Hypertension, Obstructive Sleep Apnea, Weight Related Osteoarthrosis, Type 2 DM.
Exclusion
- Participation in other weight loss program the last 12 months. Serious psychiatric conditions
Key Trial Info
Start Date :
February 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2026
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00626964
Start Date
February 1 2008
End Date
December 1 2026
Last Update
June 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Morbid Obesity Center, Vestfold Hospital Trust
Tønsberg, Norway, 3115